Related Experiment Videos
Therapeutic options after failed Helicobacter pylori eradication therapy
R W van der Hulst1, J F Weel, A van der Ende
1Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands.
The American Journal of Gastroenterology
|November 1, 1996
Summary
Retreating Helicobacter pylori infection after initial omeprazole-amoxicillin therapy failure requires new regimens. Omeprazole-clarithromycin or omeprazole-amoxicillin-metronidazole therapies offer effective H. pylori eradication options.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori (H. pylori) infection affects millions globally, increasing peptic ulcer disease risk.
- Current H. pylori eradication regimens have a 5-20% failure rate, necessitating effective retreatment strategies.
- Initial treatment failure leaves patients susceptible to severe gastrointestinal complications.
Purpose of the Study:
- To evaluate the efficacy of three retreatment regimens for H. pylori infection following initial omeprazole-amoxicillin dual therapy failure.
- To determine optimal therapeutic approaches for persistent H. pylori infections.
- To identify effective salvage therapies for H. pylori eradication.
Main Methods:
- Fifty-three patients with failed initial H. pylori treatment were randomized into four groups.
- Groups I and II received higher-dose or more frequent omeprazole with amoxicillin.
- Groups III and IV received omeprazole with amoxicillin-metronidazole or omeprazole with clarithromycin, respectively, for 14 days.
- H. pylori eradication was confirmed via biopsy culture and histology 4-6 weeks post-treatment.
Main Results:
- Retreatment with identical omeprazole-amoxicillin regimens (Groups I and II) yielded low cure rates (21% and 28%).
- Omeprazole-clarithromycin (Group IV) and omeprazole-amoxicillin-metronidazole (Group III) therapies achieved significantly higher H. pylori cure rates (70% and 75%, respectively).
- The efficacy of omeprazole-amoxicillin retreatment was independent of the omeprazole dosage.
Conclusions:
- Omeprazole-amoxicillin dual therapy, even with increased dosage, is ineffective for H. pylori retreatment after initial failure.
- Third-line H. pylori eradication attempts using omeprazole-clarithromycin or omeprazole-amoxicillin-metronidazole demonstrate considerable success.
- These findings support the use of clarithromycin- or metronidazole-containing regimens as effective salvage therapies for H. pylori infection.